These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37057287)

  • 1. PReferentially Expressed Antigen in MElanoma (PRAME): preliminary communication on a translational tool able to early detect Oral Malignant Melanoma (OMM).
    Cascardi E; Cazzato G; Ingravallo G; Dellino M; Lupo C; Casatta N; Ballini A; Pacifici A; Marenzi G; Sammartino G; Maiorano E; Tatullo M
    J Cancer; 2023; 14(4):628-633. PubMed ID: 37057287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRAME immunohistochemistry is useful in the diagnosis of oral malignant melanoma.
    Hovander D; Allen J; Oda D; Moshiri AS
    Oral Oncol; 2022 Jan; 124():105500. PubMed ID: 34452831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of PRAME Expression in 127 Acral and Nail Melanocytic Lesions.
    Santandrea G; Valli R; Zanetti E; Ragazzi M; Pampena R; Longo C; Lai M; Piana S; Cesinaro AM
    Am J Surg Pathol; 2022 May; 46(5):579-590. PubMed ID: 35275883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
    Googe PB; Flanigan KL; Miedema JR
    Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus].
    Du J; Yu WJ; Guo RP; Su J
    Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):621-626. PubMed ID: 35785832
    [No Abstract]   [Full Text] [Related]  

  • 7. PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics.
    Chen YP; Zhang WW; Qiu YT; Ke LF; Chen H; Chen G
    Histopathology; 2023 Jan; 82(2):285-295. PubMed ID: 36200756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAME Immunohistochemistry in Thin Melanomas Compared to Melanocytic Nevi.
    Zboraș I; Ungureanu L; Șenilă S; Petrushev B; Zamfir P; Crișan D; Zaharie FA; Vesa ȘC; Cosgarea R
    Diagnostics (Basel); 2024 Sep; 14(18):. PubMed ID: 39335694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions.
    Lezcano C; Jungbluth AA; Busam KJ
    Surg Pathol Clin; 2021 Jun; 14(2):165-175. PubMed ID: 34023098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRAME immunohistochemistry is useful in differentiating oral melanomas from nevi and melanotic macules.
    Schmitt TA; Lee JC; Martinka M; Ko KYC
    J Cutan Pathol; 2023 Mar; 50(3):275-278. PubMed ID: 36398487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.
    Lohman ME; Steen AJ; Grekin RC; North JP
    J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAME expression in melanocytic lesions of the nail.
    Parra O; Linos K; Li Z; Yan S
    J Cutan Pathol; 2022 Jul; 49(7):610-617. PubMed ID: 35294053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
    Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
    J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME expression in melanocytic lesions of the conjunctiva.
    Šekoranja D; Hawlina G; Pižem J
    Histopathology; 2021 Dec; 79(6):989-996. PubMed ID: 34268800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRAME Expression in Mucosal Melanoma of the Head and Neck Region.
    Ricci C; Altavilla MV; Corti B; Pasquini E; Presutti L; Baietti AM; Amorosa L; Balbi T; Baldovini C; Ambrosi F; Grillini M; D'Errico A; Fiorentino M; Foschini MP
    Am J Surg Pathol; 2023 May; 47(5):599-610. PubMed ID: 36912431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRAME/MELAN-A double immunostaining as a diagnostic tool for conjunctival melanocytic lesions: A South American experience.
    Carvajal P; Zoroquiain P
    Pathol Res Pract; 2023 Oct; 250():154776. PubMed ID: 37696245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry for Preferentially Expressed Antigen in Melanoma in the Differential Diagnosis of Melanocytic Lesions of the Nail Apparatus.
    Krajisnik A; Gharavi NM; Faries MB; Balzer BL; Frishberg DP; Martelli M; Shon W
    Am J Dermatopathol; 2022 Jul; 44(7):488-492. PubMed ID: 35120028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics.
    Rawson RV; Shteinman ER; Ansar S; Vergara IA; Thompson JF; Long GV; Scolyer RA; Wilmott JS
    Pathology; 2022 Dec; 54(7):863-873. PubMed ID: 35987723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of PRAME immunohistochemistry compared with that of c-Kit, c-Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors.
    Jung JM; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
    Pathol Int; 2023 Jan; 73(1):27-36. PubMed ID: 36468840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience.
    Cazzato G; Cascardi E; Colagrande A; Belsito V; Lospalluti L; Foti C; Arezzo F; Dellino M; Casatta N; Lupo C; Buongiorno L; Stellacci A; Marrone M; Ingravallo G; Maiorano E; Resta L
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.